HST-1/FGF-4 stimulates proliferation of megakaryocyte progenitors synergistically and promotes megakaryocyte maturation

Oncogene. 1996 Jul 4;13(1):9-19.

Abstract

Megakaryocyte (MK) development is dependent on the complex interaction of MK progenitors, various cytokines and stromal elements. We previously reported that an injection of replication-deficient adenovirus containing HST-1/FGF-4 cDNA (Adex1HST-1) into mice caused a twofold increase in peripheral platelet count for 30 days without any other hematological or histological abnormality. In the present study using Adex1HST-1-infected human megakaryocytic Dami cells, we demonstrated for the first time that HST-1/FGF-4 promoted MK maturation, inducing increases in DNA ploidy, cytoplasmic and membrane maturation, and platelet-like particle release. Moreover, HST-1/FGF-4 acted on megakaryocytic cells to induce secretion of IL-6 and TNF-alpha, and increased adhesion of megakaryocytic cells to human endothelial cells primarily via VLA-4 and LFA-1 molecules; both mechanisms have been shown to lead to MK maturation. We also showed that HST-1/FGF-4 stimulates the proliferation of MK progenitors not alone but synergistically with IL-3 via IL-6 and with c-mpl ligand (thrombopoietin) not via IL-6. This result supports the hypothesis of the presence of two distinct populations of MK progenitors: IL-3-dependent and Tpo-dependent. All these results suggest that HST-1/FGF-4 can regulate MK development not only as an MK potentiating factor, but also as an inducer of cytokine secretion from MK, and as a modulator of adhesive interactions with endothelial cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviruses, Human / genetics
  • Amino Acid Sequence
  • Animals
  • Cell Adhesion / drug effects
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cell Line
  • DNA Replication
  • Drug Synergism
  • Endothelium, Vascular / cytology
  • Fibroblast Growth Factor 4
  • Fibroblast Growth Factors / genetics
  • Fibroblast Growth Factors / pharmacology
  • Fibroblast Growth Factors / physiology*
  • Genetic Vectors / genetics
  • Humans
  • Integrin alpha4beta1
  • Integrins / metabolism
  • Interleukin-3 / pharmacology
  • Interleukin-6 / pharmacology
  • Interleukin-6 / physiology
  • Lymphocyte Function-Associated Antigen-1 / metabolism
  • Male
  • Megakaryocytes / cytology*
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Ploidies
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / pharmacology
  • Proto-Oncogene Proteins / physiology*
  • Receptors, Lymphocyte Homing / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Recombinant Fusion Proteins / pharmacology
  • Thrombopoietin / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology
  • Umbilical Veins

Substances

  • FGF4 protein, human
  • Fgf4 protein, mouse
  • Fibroblast Growth Factor 4
  • Integrin alpha4beta1
  • Integrins
  • Interleukin-3
  • Interleukin-6
  • Lymphocyte Function-Associated Antigen-1
  • Proto-Oncogene Proteins
  • Receptors, Lymphocyte Homing
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Fibroblast Growth Factors
  • Thrombopoietin